Comparison of Adjuvant regimens for cancer across tumor types #GU25. Nivolumab per Checkmate 274 for #bladdercancer rises to the top. docs.google.com/presentation...
Deputy Director at Fox Chase Cancer Center. Philadelphia USA. Professor GU Medical Oncology. Views Mine. COI: coi.asco.org/share/3BX-RW4D/Elizabe…